Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cβ -: Null mice

被引:155
作者
Ohshiro, Yuzuru
Ma, Ronald C.
Yasuda, Yutaka
Hiraoka-Yamamoto, Junko
Clermont, Allen C.
Isshiki, Keiji
Yagi, Kunimasa
Arikawa, Emi
Kern, Timothy S.
King, George L.
机构
[1] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA
[2] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
关键词
D O I
10.2337/db06-0895
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes induces the activation of several protein kinase C (PKC) isoforms in the renal glomeruli. We used PKC-beta(-/-) mice to examine the action of PKC-beta isoforms in diabetes-induced oxidative stress and renal injury at 8 and 24 weeks of disease. Diabetes increased PKC activity in renal cortex of wild-type mice and was significantly reduced (< 50% of wild-type) in diabetic PKC-beta(-/-) mice. In wild-type mice, diabetes increased the translocation of PKC-alpha and -beta 1 to the membrane, whereas only PKC-a was elevated in PKC-beta(-/-) mice. Increases in urinary isoprostane and 8-hydroxydeoxyguanosine, parameters of oxidative stress, in diabetic PKC-beta(-/-) mice were significantly reduced compared with diabetic wild-type mice. Diabetes increased NADPH oxidase activity and the expressions of p47(phox), Nox2, and Nox4 mRNA levels in the renal cortex and were unchanged in diabetic PKC-beta(-/-) mice. Increased expression of endothelin-1 (ET-1), vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-beta, connective tissue growth factor (CTGF), and collagens IV and VI found in diabetic wild-type mice was attenuated in diabetic PKC-beta(-/-) mice. Diabetic PKC-beta(-/-) mice were protected from renal hypertrophy, glomerular enlargement, and hyperfiltration observed in diabetic wild-type mice and had less proteinuria. Lack of PKC-beta can protect against diabetes-induced renal dysfunction, fibrosis, and increased expressions of Nox2 and -4, ET-1, VEGF, TGF-beta, CTGF, and oxidant production.
引用
收藏
页码:3112 / 3120
页数:9
相关论文
共 45 条
[21]  
Koya D, 1997, J AM SOC NEPHROL, V8, P426
[22]   Protein kinase C activation and the development of diabetic complications [J].
Koya, D ;
King, GL .
DIABETES, 1998, 47 (06) :859-866
[23]   Immunodeficiency in protein kinase C beta-deficient mice [J].
Leitges, M ;
Schmedt, C ;
Guinamard, R ;
Davoust, J ;
Schaal, S ;
Stabel, S ;
Tarakhovsky, A .
SCIENCE, 1996, 273 (5276) :788-791
[24]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462
[25]   Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase [J].
Li, JM ;
Shah, AM .
CARDIOVASCULAR RESEARCH, 2001, 52 (03) :477-486
[26]   DIABETIC NEPHROPATHY - A PERSPECTIVE [J].
MAUER, SM ;
STEFFES, MW ;
GOETZ, FC ;
SUTHERLAND, DER ;
BROWN, DM .
DIABETES, 1983, 32 :52-55
[27]   Diminished loss of Proteoglycans and lack of albuminuria in protein kinase C-α-deficient diabetic mice [J].
Menné, J ;
Park, JK ;
Boehne, M ;
Elger, M ;
Lindschau, C ;
Kirsch, T ;
Meier, M ;
Gueler, F ;
Fiebeler, A ;
Bahlmann, FH ;
Leitges, M ;
Haller, H .
DIABETES, 2004, 53 (08) :2101-2109
[28]  
Mishra R, 2006, BIOCHEM BIOPH RES CO, V339, P65, DOI 10.1016/j.bbrc.2005.10.180
[29]   Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats [J].
Obrosova, IG ;
Minchenko, AG ;
Vasupuram, R ;
White, L ;
Abatan, OI ;
Kumagai, AK ;
Frank, RN ;
Stevens, MJ .
DIABETES, 2003, 52 (03) :864-871
[30]   Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cell - The role of protein kinase C and NAD(P)H-oxidase activation [J].
Quagliaro, L ;
Piconi, L ;
Assaloni, R ;
Martinelli, L ;
Motz, E ;
Ceriello, A .
DIABETES, 2003, 52 (11) :2795-2804